Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Colchicine for Reducing Atrial Fibrillation Recurrence in Patients Undergoing Electrical Cardioversion

    Recruiting

    3 1 1
    Investigated Diseases:
    Denmark
  • Study on Edoxaban for Patients with Atrial Fibrillation and Coronary Syndrome Undergoing PCI

    Recruiting

    3 1 1 1
    Belgium Denmark Italy The Netherlands
  • Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Finland France Iceland The Netherlands Norway Poland +1
  • Study on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark
  • Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Croatia Czechia Estonia Finland Germany +9
  • Study on Stopping Anticoagulants in Atrial Fibrillation Patients After Surgery: Warfarin, Rivaroxaban, Apixaban, Edoxaban, Dabigatran, and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark Sweden
  • Safety of flecainide acetate compared with amiodarone hydrochloride and sotalol in patients with atrial fibrillation and stable coronary artery disease

    Not yet recruiting

    3 1 1 1
    Belgium
  • Colchicine after Electrocardioversion to Prevent Recurrence of Atrial Fibrillation in Adult Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • A study on the effect of hydrogen inhalation therapy to prevent the early return of atrial fibrillation in patients after heart ablation treatment.

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • A Study of Semaglutide in Overweight or Obese Patients with Atrial Fibrillation Scheduled for Catheter Ablation to Improve Treatment Outcomes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden